surmount 5 tirzepatide In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial results and Research Summary Tirzepatide vs Semaglutide: SURMOUNT-5 Shows
Description
Weight change can take time and may not follow a straight line
All adverse event identification, causality assessment, and regulatory reporting must be conducted by qualified pharmacovigilance professionals
Patients use Ozempic to treat type 2 diabetes and help with weight loss
C.KwongJ.LiJ
